----

----

| UNITED STATES                      |
|------------------------------------|
| SECURITIES AND EXCHANGE COMMISSION |
| WASHINGTON, DC 20549               |
|                               |   |   |
|                               |
| Form 10-K/A                        |
|  (Amendment No. 1)            |

| (Mark One) |
|------------|
| x          | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|       |   |
|       | For the fiscal year ended June 30, 2013 |
| or         |
|       |   |
| o          | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

| Commission file number: 001-35413                      |
|--------------------------------------------------------|
|                                                   |   |   |
|                                                   |
| Greenway Medical Technologies, Inc.                    |
| (Exact name of registrant as specified in its charter) |

| Delaware                                 |   | 58-2412516          |
|------------------------------------------|--------|---------------------|
| (State or Other Jurisdiction of          |   | (I.R.S. Employer    |
| Incorporation or Organization)           |   | Identification No.) |
|                                     |   |                |
| 100 Greenway Boulevard                   |   |                |
| Carrollton, GA                           |   | 30117               |
| (Address of Principal Executive Offices) |   | (Zip Code)          |

| (770) 836-3100                                              |
|-------------------------------------------------------------|
| (Registrant’s telephone number, including area code)  |
|                                                        |
| Securities registered pursuant to Section 12(b) of the Act: |

|                                      | Title of Each Class |                    |   | Name of Each Exchange on Which Registered |
|-------------------------------------------|---------------------|-------------------------|--------|-------------------------------------------|
| Common Stock, par value $0.0001 per share |                | New York Stock Exchange |

| Securities registered pursuant to Section 12(g) of the Act: |
|-------------------------------------------------------------|
|                                                        | None |   |

|                    |   |                                          |                      |   |
|-------------------------|--------|-----------------------------------------------|---------------------------|--------|
| Large accelerated filer | o      |                                          | Accelerated filer         | x      |
| Non-accelerated filer   | o      | (Do not check if a smaller reporting company) | Smaller reporting company | o      |

|                                |   |   |
|-------------------------------------|--------|--------|
|                                |
| DOCUMENTS INCORPORATED BY REFERENCE |

----

----

 

|       | Page                                                                                            |
|------------|-------------------------------------------------------------------------------------------------|
|       |                                                                                            |   |
| PART III   |                                                                                            |   |
| Item 10.   | Directors, Executive Officers and Corporate Governance.                                         | 3 |
| Item 11.   | Executive Compensation.                                                                         | 6 |
| Item 12.   | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. | 15 |
| Item 13.   | Certain Relationships and Related Transactions, and Director Independence.                      | 18 |
| Item 14.   | Principal Accountant Fees and Services.                                                         | 19 |
| PART IV    |                                                                                            |   |
| Item 15.   | Exhibits and Financial Statement Schedules                                                      | 20 |
| SIGNATURES |                                                                                            | 22 |

 

 

|   | Name                              |   |   | Age |   |   | Position                                             |   |
|--------|-----------------------------------|--------|--------|-----|--------|--------|------------------------------------------------------|--------|
|   | W. Thomas Green, Jr.              |   |   | 69  |   |   | Chairman of the Board                                |   |
|   | Wyche T. Green, III               |   |   | 41  |   |   | President, Chief Executive Officer and Director      |   |
|   | Thomas T. Richards                |   |   | 73  |   |   | Director                                             |   |
|   | Walter Turek                      |   |   | 61  |   |   | Director                                             |   |
|   | Robert Z. Hensley                 |   |   | 56  |   |   | Director                                             |   |
|   | D. Neal Morrison                  |   |   | 52  |   |   | Director                                             |   |
|   | Noah Walley                       |   |   | 50  |   |   | Director                                             |   |
|   | Gregory H. Schulenburg            |   |   | 48  |   |   | Executive Vice President and Chief Operating Officer |   |
|   | James A. “Al” Cochran |   |   | 66  |   |   | Chief Financial Officer                              |   |
|   | William G. Esslinger, Jr.         |   |   | 42  |   |   | Vice President, General Counsel and Secretary        |   |

 

 

|   | ● | reviewed and discussed the consolidated financial statements of the Company set forth in the Company’s Annual Report on Form 10-K for the year ended June 30, 2013 with management of the Company and Grant Thornton LLP, independent registered public accounting firm for the Company; |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● | discussed with Grant Thornton LLP the matters required to be discussed by Statement on Auditing Standards No. 61, as amended, (AICPA, Professional Standards, Vol. 1. AU section 380), as adopted by the Public Company Accounting Oversight Board in Rule 3200T;  |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|   | ● | received the written disclosures and the letter from Grant Thornton LLP required by applicable requirements of the Public Company Accounting Oversight Board regarding Grant Thornton LLP’s communications with the Audit Committee concerning independence, and has discussed with the independent registered public accounting firm the firm’s independence from Company management and the Company; and |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● | based on the review and discussions with management of the Company and Grant Thornton LLP referred to above, recommended to the Board that the audited financial statements be included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2013.  |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | AUDIT COMMITTEE |
|--------|-----------------|

|   | Robert Z. Hensley, Chairman |
|--------|-----------------------------|

|   | Thomas T. Richards |
|--------|--------------------|

|   | Walter Turek |
|--------|--------------|

 

 

 

|   Name                      |   |   | Total number ofoptions granted |
|---------------------------------------|--------|--------|--------------------------------|
|   Wyche T. Green, III       |   |   | 106,000                        |   |
|   James A. Cochran          |   |   | 41,000                         |   |
|   W. Thomas Green, Jr.      |   |   | 43,000                         |   |
|   Gregory H. Schulenburg    |   |   | 42,000                         |   |
|   William G. Esslinger, Jr. |   |   | 32,000                         |   |

 

|   | Respectfully submitted, |
|--------|-------------------------|
|   |                    |
|   | Noah Walley, Chair      |
|   | D. Neal Morrison        |
|   | Walter Turek            |

 

| Name and principal position |   | Year   |   |   | Salary($) |   |    | Non-equityincentiveplancompensation($)(1) |   |   | Optionawards($)(2)(3) |   |   | All othercompensation($) |      |   | Total($) |   |
|-----------------------------|--------|--------|--------|--------|-----------|--------|---------|-------------------------------------------|--------|--------|-----------------------|--------|--------|--------------------------|-----------|--------|----------|--------|
| Wyche T. Green, III,        |   |   | 2013   |   |      |   | 402,500 |                                      |   |   | —               |   |   |                     | 913,720   |   |     |   | — |   |   |   | 1,316,220 |   |
| President and Chief         |   |   | 2012   |   |      |   | 350,000 |                                      |   |   | 261,818               |   |   |                     | 1,173,850 |   |     |   | — |   |   |   | 1,785,668 |   |
| Executive Officer           |   |   | 2011   |   |      |   | 325,373 |                                      |   |   | 226,469               |   |   |                     | 392,400   |   |     |   | — |   |   |   | 944,242 |   |
| James A. Cochran, Chief     |   |   | 2013   |   |      |   | 275,865 |                                      |   |   | —               |   |   |                     | 353,420   |   |     |   | — |   |   |   | 629,285 |   |
| Financial Officer           |   |   | 2012   |   |      |   | 248,000 |                                      |   |   | 154,597               |   |   |                     | 440,320   |   |     |   | — |   |   |   | 842,917 |   |
|                        |   |   | 2011   |   |      |   | 247,676 |                                      |   |   | 172,587               |   |   |                     | —   |   |     |   | — |   |   |   | 420,263 |   |
| W. Thomas Green,            |   |   | 2013   |   |      |   | 288,000 |                                      |   |   | —               |   |   |                     | 370,660   |   |     |   | — |   |   |   | 658,660 |   |
| Jr., Chairman               |   |   | 2012   |   |      |   | 288,000 |                                      |   |   | 179,532               |   |   |                     | 613,636   |   |     |   | — |   |   |   | 1,081,168 |   |
|                        |   |   | 2011   |   |      |   | 288,000 |                                      |   |   | 200,687               |   |   |                     | 44,888    |   |     |   | — |   |   |   | 533,575 |   |
| Gregory H. Schulenburg,     |   |   | 2013   |   |      |   | 279,134 |                                      |   |   | —               |   |   |                     | 362,040   |   |     |   | — |   |   |   | 641,174 |   |
| Executive Vice President    |   |   | 2012   |   |      |   | 265,000 |                                      |   |   | 165,194               |   |   |                     | 534,660   |   |     |   | — |   |   |   | 964,854 |   |
| and Chief Operating Officer |   |   | 2011   |   |      |   | 223,353 |                                      |   |   | 155,639               |   |   |                     | 249,248   |   |     |   | — |   |   |   | 628,240 |   |
| William G. Esslinger, Jr.,  |   |   | 2013   |   |      |   | 212,115 |                                      |   |   | —               |   |   |                     | 275,840   |   |     |   | — |   |   |   | 487,955 |   |
| Vice President,             |   |   | 2012   |   |      |   | 200,000 |                                      |   |   | 99,740                |   |   |                     | 386,715   |   |     |   | — |   |   |   | 686,455 |   |
| General Counsel and         |   |   | 2011   |   |      |   | 173,254 |                                      |   |   | 69,500                |   |   |                     | 43,874    |   |     |   | — |   |   |   | 286,628 |   |
| Secretary                   |   |   |   |   |      |   |    |                                      |   |   |                  |   |   |                     |      |   |     |   |   |   |   |   |   |   |

----

| (1) | Please see “Compensation Discussion and Analysis- Annual Cash Incentives” for more information about the Company’s 2013 Incentive Bonus Plan. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | The amount represents the aggregate grant date fair value of option awards granted in the fiscal year valued in accordance with FASB ASC Topic 718. This amount does not represent our accounting expense for these awards during the year and does not correspond to the actual cash value recognized when received. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | On September 24, 2012, the following option awards were granted that vest over four years, with 25% vesting in September 2013 and the remainder vesting over three years thereafter in equal monthly installments: Wyche T. Green, III received options for 106,000 shares; James A. Cochran received options for 41,000 shares; W. Thomas Green, Jr. received options for 43,000 shares; Gregory H. Schulenburg received options for 42,000 shares, and William G. Esslinger, Jr. received options for 32,000 shares. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|                                                                         |   |               |      |   |                                                                |   |    |      |   |   |       |   |   |  Grantdate fairvalue ofstock andoptionawards($)              |    |
|------------------------------------------------------------------------------|--------|--------------------|-----------|--------|---------------------------------------------------------------------|--------|---------|-----------|--------|--------|------------|--------|--------|-------------------------------------------------------------------|---------|
|                                                                         |   |               |      |   | Estimated possible payouts undernon-equity incentive plan awards(1) |   |    |      |   |   |       |   |   |                                                              |
| Name and principal position                                                  |   |  Grantdate($) |      |   | Threshold($)                                                        |   |    | Target($) |   |   | Maximum($) |   |   | All other optionawards: number ofsecuritiesunderlying options (#) |    |   | Exercise orbase price ofoptionawards ($/Sh) |   |   |   |
| Wyche T. Green, III,President and Chief Executive Officer                    |   |               | 9/24/2012 |   |                                                                |   | 167,500 |      |   |   | 249,000    |   |   |                                                              | 498,000 |   |   |   | 106,000 | ​(2) |   |   | 15.99 |   |   |   | 913,720 |   |
| James A. Cochran, Chief Financial Officer                                    |   |               | 9/24/2012 |   |                                                                |   | 92,000  |      |   |   | 141,000    |   |   |                                                              | 282,000 |   |   |   | 41,000 | ​(2) |   |   | 15.99 |   |   |   | 353,420 |   |
| W. Thomas Green, Jr., Chairman                                               |   |               | 9/24/2012 |   |                                                                |   | 94,800  |      |   |   | 144,000    |   |   |                                                              | 288,000 |   |   |   | 43,000 | ​(2) |   |   | 15.99 |   |   |   | 370,660 |   |
| Gregory H. Schulenburg, Executive Vice President and Chief Operating Officer |   |               | 9/24/2012 |   |                                                                |   | 92,000  |      |   |   | 141,000    |   |   |                                                              | 242,000 |   |   |   | 42,000 | ​(2) |   |   | 15.99 |   |   |   | 362,040 |   |
| William G. Esslinger, Jr., Vice President, General Counsel and Secretary     |   |               | 9/24/2012 |   |                                                                |   | 56,000  |      |   |   | 86,000     |   |   |                                                              | 172,000 |   |   |   | 32,000 | ​(2) |   |   | 15.99 |   |   |   | 275,840 |   |

----

|   | (1) | Amounts in the “Estimated Possible Payouts Under Non-Equity Incentive Plan Awards” column relate to amounts payable under our 2013 Incentive Bonus Plan at the time the grants of awards were made. The actual amounts paid to our Named Executive Officers are set forth in the “2013 Summary Compensation Table” above. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | (2) | The option vests over four years, with 25% vesting in September 2013 and the remainder vesting over three years thereafter in equal monthly installments.                                                                                                                                                                                         |

 

|                                                                         |   |                                                        |    |   |                                                                |   |    |                    |   |   |                 |   |   |   |       |   |
|------------------------------------------------------------------------------|--------|-------------------------------------------------------------|---------|--------|---------------------------------------------------------------------|--------|---------|-------------------------|--------|--------|----------------------|--------|--------|--------|------------|--------|
|                                                                         |   | Option awards                                               |    |
| Name                                                                         |   | Number ofsecuritiesunderlyingunexercised optionsexercisable |    |   |  Number ofsecuritiesunderlyingunexercised optionsunexercisable |   |    | Optionexerciseprice ($) |   |   | Optionexpirationdate |   |
| Wyche T. Green, III, President and Chief Executive Officer                   |   |                                                        | 20,000  |   |                                                                |   | — |                    |   |   | 4.75                 |   |   |   | 2/16/2015  |   |
|                                                                         |   |                                                        | 54,700  |   |                                                                |   | — |                    |   |   | 4.75                 |   |   |   | 8/18/2015  |   |
|                                                                         |   |                                                        | 75,701  |   |                                                                |   | — |                    |   |   | 4.75                 |   |   |   | 10/18/2017 |   |
|                                                                         |   |                                                        | 4,184   |   |                                                                |   | — |                    |   |   | 4.75                 |   |   |   | 9/18/2018  |   |
|                                                                         |   |                                                        | 500     |   |                                                                |   | — |                    |   |   | 5.19                 |   |   |   | 9/15/2019  |   |
|                                                                         |   |                                                        | 26,875  |   |                                                                |   | 3,125   | (1)                     |   |   | 5.19                 |   |   |   | 11/4/2019  |   |
|                                                                         |   |                                                        | 10,625  |   |                                                                |   | 4,375   | (2)                     |   |   | 6.92                 |   |   |   | 10/18/2020 |   |
|                                                                         |   |                                                        | 72,917  |   |                                                                |   | 52,083  | (3)                     |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 7,188   |   |                                                                |   | 7,812   | (4)                     |   |   | 13.31                |   |   |   | 7/14/2021  |   |
|                                                                         |   |                                                        | 29,114  |   |                                                                |   | 78,386  | (5)                     |   |   | 16.25                |   |   |   | 5/30/2022  |   |
|                                                                         |   |                                                        | — |   |                                                                |   | 106,000 | (7)                     |   |   | 15.99                |   |   |   | 9/24/2022  |   |
| James A. Cochran, Chief Financial Officer                                    |   |                                                        | 14,225  |   |                                                                |   | 14,444  | (1)                     |   |   | 5.19                 |   |   |   | 11/4/2019  |   |
|                                                                         |   |                                                        | 11,645  |   |                                                                |   | 31,355  | (5)                     |   |   | 16.25                |   |   |   | 5/30/2022  |   |
|                                                                         |   |                                                        | — |   |                                                                |   | 41,000  | (7)                     |   |   | 15.99                |   |   |   | 9/24/2022  |   |
| W. Thomas Green, Jr., Chairman                                               |   |                                                        | 58,912  |   |                                                                |   | — |                    |   |   | 4.75                 |   |   |   | 8/18/2015  |   |
|                                                                         |   |                                                        | 70,505  |   |                                                                |   | — |                    |   |   | 4.75                 |   |   |   | 10/18/2017 |   |
|                                                                         |   |                                                        | 7,766   |   |                                                                |   | — |                    |   |   | 4.75                 |   |   |   | 9/18/2018  |   |
|                                                                         |   |                                                        | 500     |   |                                                                |   | — |                    |   |   | 5.19                 |   |   |   | 9/15/2019  |   |
|                                                                         |   |                                                        | 30,235  |   |                                                                |   | 3,515   | (1)                     |   |   | 5.19                 |   |   |   | 11/4/2019  |   |
|                                                                         |   |                                                        | 11,954  |   |                                                                |   | 4,921   | (2)                     |   |   | 6.92                 |   |   |   | 10/18/2020 |   |
|                                                                         |   |                                                        | 8,086   |   |                                                                |   | 8,789   | (4)                     |   |   | 13.31                |   |   |   | 7/14/2021  |   |
|                                                                         |   |                                                        | 14,056  |   |                                                                |   | 37,844  | (5)                     |   |   | 16.25                |   |   |   | 5/30/2022  |   |
|                                                                         |   |                                                        | — |   |                                                                |   | 43,000  | (7)                     |   |   | 15.99                |   |   |   | 9/24/2022  |   |
| Gregory H. Schulenburg, Executive Vice President and Chief Operating Officer |   |                                                        | 6,000   |   |                                                                |   | — |                    |   |   | 5.19                 |   |   |   | 9/15/2019  |   |
|                                                                         |   |                                                        | 11,198  |   |                                                                |   | 1,302   | (1)                     |   |   | 5.19                 |   |   |   | 11/4/2019  |   |
|                                                                         |   |                                                        | 308     |   |                                                                |   | — |                    |   |   | 6.92                 |   |   |   | 6/30/2020  |   |
|                                                                         |   |                                                        | 4,428   |   |                                                                |   | 1,822   | (2)                     |   |   | 6.92                 |   |   |   | 10/18/2020 |   |
|                                                                         |   |                                                        | 851     |   |                                                                |   | — |                    |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 25,000  |   |                                                                |   | — |                    |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 25,000  |   |                                                                |   | — |                    |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 2,000   |   |                                                                |   | — |                    |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 135     |   |                                                                |   | 96      | (3)                     |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 1,750   |   |                                                                |   | 1,250   | (3)                     |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 15,416  |   |                                                                |   | 11,010  | (3)                     |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 1,875   |   |                                                                |   | 1,875   | (6)                     |   |   | 11.58                |   |   |   | 6/28/2021  |   |
|                                                                         |   |                                                        | 2,995   |   |                                                                |   | 3,255   | (4)                     |   |   | 13.31                |   |   |   | 7/14/2021  |   |
|                                                                         |   |                                                        | 12,945  |   |                                                                |   | 34,855  | (5)                     |   |   | 16.25                |   |   |   | 5/30/2022  |   |
|                                                                         |   |                                                        | — |   |                                                                |   | 42,000  | (7)                     |   |   | 15.99                |   |   |   | 9/24/2022  |   |
| William G. Esslinger, Jr., Vice President, General Counsel and Secretary     |   |                                                        | 4,480   |   |                                                                |   | 520     | (1)                     |   |   | 5.19                 |   |   |   | 11/4/2019  |   |
|                                                                         |   |                                                        | 20,000  |   |                                                                |   | — |                    |   |   | 6.92                 |   |   |   | 6/30/2020  |   |
|                                                                         |   |                                                        | 1,771   |   |                                                                |   | 729     | (2)                     |   |   | 6.92                 |   |   |   | 10/18/2020 |   |
|                                                                         |   |                                                        | 133     |   |                                                                |   | — |                    |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 2,000   |   |                                                                |   | — |                    |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 5,834   |   |                                                                |   | 4,166   | (3)                     |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 623     |   |                                                                |   | 444     | (3)                     |   |   | 7.09                 |   |   |   | 2/1/2021   |   |
|                                                                         |   |                                                        | 3,750   |   |                                                                |   | 3,750   | (6)                     |   |   | 11.58                |   |   |   | 6/28/2021  |   |
|                                                                         |   |                                                        | 1,198   |   |                                                                |   | 1,302   | (4)                     |   |   | 13.31                |   |   |   | 7/14/2021  |   |
|                                                                         |   |                                                        | 9,750   |   |                                                                |   | 26,250  | (5)                     |   |   | 16.25                |   |   |   | 5/30/2022  |   |
|                                                                         |   |                                                        | — |   |                                                                |   | 32,000  | (7)                     |   |   | 15.99                |   |   |   | 9/24/2022  |   |

----

| (1) | The option vests over four years, with 25% vesting in November 2010 and the remainder vesting over three years thereafter in monthly installments.  |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | The option vests over four years, with 25% vesting in August 2011 and the remainder vesting over three years thereafter in monthly installments.    |
| (3) | The option vests over four years, with 25% vesting in February 2012 and the remainder vesting over three years thereafter in monthly installments.  |
| (4) | The option vests over four years, with 25% vesting in July 2012 and the remainder vesting over three years thereafter in monthly installments.      |
| (5) | The option vests over four years, with 25% vesting in May 2013 and the remainder vesting over three years thereafter in monthly installments.       |
| (6) | The option vests over four years, with 25% vesting in June 2012 and the remainder vesting over three years thereafter in monthly installments.      |
| (7) | The option vests over four years, with 25% vesting in September 2013 and the remainder vesting over three years thereafter in monthly installments. |

 

|   | ● | the aggregate dollar amount realized on the exercise date for such options computed by multiplying the number of shares acquired by the difference between the market value of the shares on the exercise date and the exercise price of the options. |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | ● | the number of shares of common stock acquired by the executives named in the Summary Compensation Table upon the exercise of stock options during the fiscal year ended June 30, 2013.                                                                |

|                      |   | Option awards                            |    |
|---------------------------|--------|------------------------------------------|---------|
| Name                      |   | Number of sharesacquired on exercise (#) |    |   | Value realized onexercise ($) |   |
| Wyche T. Green, III       |   |                                     | 34,044  |   |   |   | 303,332 |   |
| James A. Cochran          |   |                                     | 110,000 |   |   |   | 1,286,750 |   |
| W. Thomas Green, Jr.      |   |                                     | 144,851 |   |   |   | 1,290,622 |   |
| Gregory H. Schulenburg    |   |                                     | 18,175  |   |   |   | 202,720 |   |
| William G. Esslinger, Jr. |   |                                     | 16,576  |   |   |   | 148,937 |   |

 

| Name               |   | Feesearned orpaid$ |   |   | Stockawards |   |   | Optionawards(1)(2)$ |   |   | Non-equityincentiveplancompensation |    |   | Change inpensionvalue andNQDCearnings |    |   | All othercompensation |    |   | Total$ |   |
|--------------------|--------|--------------------|--------|--------|-------------|--------|--------|---------------------|--------|--------|-------------------------------------|---------|--------|---------------------------------------|---------|--------|-----------------------|---------|--------|--------|--------|
| Noah Walley        |   | 38,750             |   |   | —     |   |   |                | 46,144 |   |                                | — |   |                                  | — |   |                  | — |   |   |   | 84,894 |   |
| Thomas T. Richards |   | 28,750             |   |   | —     |   |   |                | 46,144 |   |                                | — |   |                                  | — |   |                  | — |   |   |   | 74,894 |   |
| Walter Turek       |   | 36,250             |   |   | —     |   |   |                | 46,144 |   |                                | — |   |                                  | — |   |                  | — |   |   |   | 82,394 |   |
| D. Neal Morrison   |   | 28,750             |   |   | —     |   |   |                | 46,144 |   |                                | — |   |                                  | — |   |                  | — |   |   |   | 74,894 |   |
| Robert Z. Hensley  |   | 43,750             |   |   | —     |   |   |                | 46,144 |   |                                | — |   |                                  | — |   |                  | — |   |   |   | 89,894 |   |

|   | (1)(1)    | The amount represents the aggregate grant date fair value of option awards granted in the fiscal year valued in accordance with FASB ASC Topic 718. This amount does not represent our accounting expense for these awards during the year and does not correspond to the actual cash value recognized by the director when received.                                                                                                                                                                                                       |
|--------|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |   |
|   | (2)  | On September 14, 2012, Messrs. Walley, Richards, Turek, Morrison, and Hensley received options to purchase 5,600 shares of common stock at an exercise price of $15.28. These options were 2/12 vested upon the date of grant, and 1/12 vested on the last day of each month thereafter for the following ten months. The aggregate number of option awards outstanding as of June 30, 2013, for each director was as follows: Mr. Walley, 22,300, Mr. Richards, 33,425, Mr. Turek, 112,300, Mr. Morrison, 22,300; and Mr. Hensley, 16,050. |

|   | ● | each stockholder, or group of affiliated stockholders, who we know beneficially owns more than 5% of the outstanding shares of our common stock; |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------|
|   | ● | each of our current directors;                                                                                                                   |
|   | ● | each of our named executive officers; and                                                                                                        |
|   | ● | all of our current directors and current executive officers as a group.                                                                          |

 

| Name of Beneficial Owner                                                |   | Amount andNature ofBeneficialOwnership(1) |      |   | Percent ofOutstandingShares |   |
|-------------------------------------------------------------------------|--------|-------------------------------------------|-----------|--------|-----------------------------|--------|
| 5% Stockholders                                                         |   |                                      |      |   |                        |   |
| Investor Group L.P.(2)                                                  |   |                                      | 2,109,431 |   |                        |   | 7.1 | % |
| Investor Growth Capital Limited(3)                                      |   |                                      | 4,922,009 |   |                        |   | 16.5 | % |
| Pamlico Capital II, L.P.(4)                                             |   |                                      | 5,294,679 |   |                        |   | 17.7 | % |
| Named Executive Officers and Directors                                  |   |                                      |      |   |                        |   |   |   |
| W. Thomas Green, Jr.(5)                                                 |   |                                      | 2,305,663 |   |                        |   | 7.7 | % |
| Wyche T. Green, III(6)                                                  |   |                                      | 648,477   |   |                        |   | 2.1 | % |
| Gregory H. Schulenburg(7)                                               |   |                                      | 171,749   |   |                        |   | * |   |
| James A. Cochran(8)                                                     |   |                                      | 132,606   |   |                        |   | * |   |
| William G. Esslinger, Jr.(9)                                            |   |                                      | 147,351   |   |                        |   | * |   |
| Robert Hensley(10)                                                      |   |                                      | 25,050    |   |                        |   | * |   |
| Neal Morrison(11)                                                       |   |                                      | 22,300    |   |                        |   | * |   |
| Thomas T. Richards(12)                                                  |   |                                      | 339,963   |   |                        |   | 1.1 | % |
| Walter Turek(13)                                                        |   |                                      | 153,300   |   |                        |   | * |   |
| Noah Walley(14)                                                         |   |                                      | 22,300    |   |                        |   | * |   |
| All directors and executive officers as a group (10 persons)​(15) |   |                                      | 3,968,759 |   |                        |   | 12.8 | % |

| *         | less than 1%.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  (1) |  This column lists all shares of common stock beneficially owned, including all shares of common stock that can be acquired through warrant or option exercises within 60 days of October 25, 2013.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|  (2) |  Based on the Form 13G filed by Investor AB on February 13, 2013. Investor AB, a publicly traded company on the Stockholm Stock Exchange, is the beneficial owner of the shares held by Investor Group L.P. (“IGLP”), but holds no voting or investment control over the shares. Stephen M. Campe, Lennart Johansson and Michael V. Oporto are the directors of Investor Growth Capital LLC, the general partner of IGLP, and may be considered to share voting and dispositive power over the shares held by IGLP. The address of IGLP is Canada Court, Upland Road, St. Peter Port, GY1 3BQ, Guernsey. IGLP is an affiliate of Investor Growth Capital Limited (“IGCL”). |
|  (3) |  Based on the Form 13G filed by Investor AB on February 13, 2013. Investor AB, a publicly traded company on the Stockholm Stock Exchange, is the beneficial owner of the shares held by IGCL, but holds no voting or investment control over the shares. Stephen M. Campe, Lennart Johansson and Michael V. Oporto are the directors of IGCL and may be considered to share voting and dispositive power over the shares held by IGCL. The address of IGCL is Clifton House, 75 Fort Street, PO Box 1350, Grand Cayman KY1-1108, Cayman Islands. IGCL is an affiliate of IGLP.                                                                                                                     |

 
| (4)        | Based on the Schedule 13D/A filed with the SEC on September 27, 2013. Pamlico Capital GP II, LLC is the general partner of Pamlico Capital II, L.P. (“Pamlico”) and the managing members of the general partner are Scott B. Perper, L. Watts Hamrick, III and Frederick W. Eubank, II. These individuals may be deemed to have shared voting and investment power over the shares held by Pamlico. The address of Pamlico is 150 North College Street, Suite 2400, Charlotte, NC 28202.                                                                                                                                                                                                                                                                                                     |
|------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  (5)  |  Shares beneficially owned by Mr. Green include (i) 849,231 shares held by Mr. Green, (ii) 244,818 shares held by Elizabeth J. Green, Mr. Green’s spouse, (iii) 967,473 shares held by the W. T. Green, Jr. Family Limited Partnership, (iv) 10,500 shares held in Mr. Green’s IRA, (v) 4,650 shares held in Ms. Green’s IRA, (vi) 400 shares held in trust for which Mr. Green serves as trustee, and (vii) 228,591 shares of common stock issuable upon exercise of stock options, of which 222,528 are currently vested and 6,063 will vest within the next 60 days. 870,094 shares of common stock beneficially owned by Mr. Green are pledged as security for a loan.                                                                                                        |
|  (6)  |  Shares beneficially owned by Mr. Green include (i) 62,236 shares held by Mr. Green, (ii) 9,600 shares held by Jennifer Green, Mr. Green’s spouse, (iii) 198,764 shares held by the T&J Green Family Partnership LP, (iv) 9,250 shares held in Mr. Green’s IRA, and (v) 368,627 shares of common stock issuable upon exercise of stock options, of which 352,648 are currently vested and 15,979 will vest within the next 60 days. 270,100 shares of common stock beneficially owned by Mr. Green are pledged as security for a loan.                                                                                                                                                                                                                                              |
|  (7)  |  Shares beneficially owned by Mr. Schulenburg include (i) 24,280 shares held by Mr. Schulenburg, (ii) 12,500 shares held in an IRA, and (iii) 134,969 shares of common stock issuable upon exercise of stock options, of which 129,053 are currently vested and 5,916 will vest within the next 60 days. 24,280 shares of common stock beneficially owned by Mr. Schulenburg are pledged as security for a loan.                                                                                                                                                                                                                                                                                                                                                                                    |
|  (8)  |  Shares beneficially owned by Mr. Cochran include (i) 75,000 shares held by Mr. Cochran and (ii) 57,606 shares of common stock issuable upon exercise of stock options, of which 51,218 are currently vested and 6,388 will vest within the next 60 days. 75,000 shares of common stock beneficially owned by Mr. Cochran are pledged as security for a loan.                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|  (9)  |  Shares beneficially owned by Mr. Esslinger include (i) 35,057 shares held by Mr. Esslinger, (ii) 616 shares held in Mr. Esslinger’s IRA, (iii) 1,748 shares held in his spouse’s IRA, (iv) 66,600 shares of common stock issuable to Mr. Esslinger upon exercise of stock options, of which 62,680 are currently vested and 3,920 will vest within the next 60 days, and (v) 43,330 shares of common stock issuable to his spouse upon exercise of stock options, all of which are currently vested. 35,057 shares of common stock beneficially owned by Mr. Esslinger are pledged as security for a loan.                                                                                                                                                                             |
|  (10) |  Shares beneficially owned by Mr. Hensley include (i) 9,000 shares held by Mr. Hensley and (ii) 16,050 shares of common stock issuable upon exercise of stock options, all of which are currently vested.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|  (11) |  Shares beneficially owned by Mr. Morrison include 22,300 shares of common stock issuable upon exercise of stock options, all of which are currently vested. Mr. Morrison is a member of Pamlico Capital GP II, LLC, which is the general partner of, and has a one percent interest in the investments of, Pamlico.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|  (12) |  Shares beneficially owned by Mr. Richards include (i) 273,037 shares held by Mr. Richards, (ii) 21,000 shares held by Cornelia S. Richards, the spouse of Mr. Richards, (iii) 4,167 shares held by the Margaret Richards Bass Family Trust (the “Bass Trust”), of which Ms. Richards is trustee, (iv) 8,334 shares held by the Cornelia Lucas Richards Family Trust (the “Richards Trust”), of which Ms. Richards is trustee, (v) 33,425 shares of common stock issuable to Mr. Richards upon exercise of stock options, all of which are currently vested. Mr. Richards disclaims beneficial ownership of the shares held by the Bass Trust and the Richards Trust. 242,537 shares of common stock beneficially owned by Mr. Richards are pledged as security for a loan. |
|  (13) |  Shares beneficially owned by Mr. Turek include (i) 41,000 shares held by Mr. Turek and (ii) 112,300 shares of common stock issuable upon exercise of stock options, all of which are currently vested.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

 
| (14)       | Shares beneficially owned by Mr. Walley include 22,300 shares of common stock issuable upon exercise of stock options, all of which are currently vested. Mr. Walley is a limited partner of IGLP and is head of North American technology investing for an affiliate company of IGLP and IGCL. |
|------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  (15) |  Shares beneficially owned include 1,106,098 shares of common stock issuable upon exercise of stock options.                                                                                                                                                                          |

 

|               |   | 2013   |    |   | 2012   |   |
|--------------------|--------|--------|---------|--------|--------|--------|
| Audit fees         |   | $      | 235,241 |   |   | $      | 122,177 |   |
| Audit-related fees |   |   | — |   |   |   | 633,994 |   |
| Tax fees           |   |   | 33,800  |   |   |   | 179,437 |   |
| All other fees     |   |   | — |   |   |   | — |   |
| Total fees         |   | $      | 269,041 |   |   | $      | 935,608 |   |

 

| Item 15. | Exhibits and Financial Statement Schedules |
|----------|--------------------------------------------|

|          |   |                                                                                                                                                                                                                                                                                                                                                            |
|---------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ExhibitNumber |   | Description of Document                                                                                                                                                                                                                                                                                                                                         |
| 3.1           |   | Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.2 to the Company’s Form S-1/A (File No. 333-175619) filed on January 18, 2012)                                                                                                                                                                                        |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 3.2           |   | Bylaws of the Company (incorporated by reference to Exhibit 3.3 to the Company’s Form S-1/A (File No. 333-175619) filed on January 18, 2012)                                                                                                                                                                                                              |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 4.1           |   | Form of the Company’s Common Stock Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Form S-1/A (File No. 333-175619) filed on January 18, 2012)                                                                                                                                                                               |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 4.2.1         |   | Form of the Company’s Series A Preferred Stock Certificate (incorporated by reference to Exhibit 4.2 to the Company’s Form S-1/A (File No. 333-175619) filed on September 23, 2011)                                                                                                                                                                 |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 4.2.2         |   | Form of the Company’s Series B Preferred Stock Certificate (incorporated by reference to Exhibit 4.3 to the Company’s Form S-1/A (File No. 333-175619) filed on September 23, 2011)                                                                                                                                                                 |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 4.3           |   | Amended and Restated Investors’ Rights Agreement, by and among Greenway Medical Technologies, Inc. and the investors listed on Schedule A thereto, dated October 30, 2006(incorporated by reference to Exhibit 4.2 to the Company’s Form S-1 (File No. 333-175619) filed on July 15, 2011)                                                          |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 4.4           |   | Second Amended and Restated Voting Agreement by and among Greenway Medical Technologies, Inc. and the investors listed on the schedules thereto dated October 30, 2006 (incorporated by reference to the Company’s Form S-1/A (incorporated by reference to Exhibit 4.3 to the Company’s Form S-1/A (File No. 333-175619) filed on August 26, 2011) |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 10.1*         |   | Greenway Medical Technologies, Inc. 2011 Stock Plan (incorporated by reference to Exhibit 10.1 to the Company’s Form S-1/A (File No. 333-175619) filed on January 18, 2012)                                                                                                                                                                               |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 10.2*         |   | Greenway Medical Technologies, Inc. 2004 Stock Plan (incorporated by reference to Exhibit 10.2 to the Company’s Form S-1/A (File No. 333-175619) filed on August 26, 2011)                                                                                                                                                                                |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 10.2.1*       |   | 2004 Stock Plan Form of ISO and NSO Notice of Stock Option Grant and Stock Option Agreement (incorporated by reference to Exhibit 10.2.1 to the Company’s Form S-1/A (File No. 333-175619) filed on August 26, 2011)                                                                                                                                      |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 10.2.2*       |   | Amendment to 2004 Stock Plan (incorporated by reference to Exhibit 10.2.2 to the Company’s Form S-1/A (File No. 333-175619) filed on January 18, 2012)                                                                                                                                                                                                    |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 10.3*         |   | Greenway Medical Technologies 1999 Stock Option Plan, as amended (incorporated by reference to Exhibit 10.3 to the Company’s Form S-1/A (File No. 333-175619) filed on August 26, 2011)                                                                                                                                                                   |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 10.3.1*       |   | 1999 Stock Option Plan Form of ISO Agreement (incorporated by reference to Exhibit 10.3.1 to the Company’s Form S-1/A (File No. 333-175619) filed on August 26, 2011)                                                                                                                                                                                     |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 10.3.2*       |   | 1999 Stock Option Plan Form of Non-Qualified Stock Option Agreement (incorporated by reference to Exhibit 10.3.2 to the Company’s Form S-1/A (File No. 333-175619) filed on August 26, 2011)                                                                                                                                                              |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 10.4*         |   | Form of Indemnification Agreement by and between Greenway Medical Technologies, Inc. and each of its directors (incorporated by reference to Exhibit 10.4 to the Company’s Form S-1/A (File No. 333-175619) filed on January 18, 2012)                                                                                                                    |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 10.5          |   | Triple Net Lease, by and between Elizabeth Village, LLC and Greenway Medical Technologies, Inc., dated as of July 1, 2000 (incorporated by reference to Exhibit 10.5 to the Company’s Form S-1 (File No. 333-175619) filed on July 15, 2011)                                                                                                              |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |
| 10.6          |   | Credit Agreement, among Greenway Medical Technologies, Inc., Bank of America, N.A., and the other lenders, named therein, dated as of March 22, 2011 (incorporated by reference to Exhibit 10.6 to the Company’s Form S-1/A (File No. 333-175619) filed on August 26, 2011)                                                                               |
|          |   |                                                                                                                                                                                                                                                                                                                                                            |

| 10.6.1   |   | Amendment to Credit Agreement (incorporated by reference to Exhibit 10.6.1 to the Company’s Form S-1/A (File No. 333-175619) filed on December 5, 2011)                                                                                         |
|----------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|     |   |                                                                                                                                                                                                                                                  |
| 10.6.2   |   | Second Amendment to Credit Agreement (incorporated by reference to Exhibit 10.6.2 to the Company’s Form S-1/A (File No. 333-175619) filed on January 18, 2012)                                                                                  |
|     |   |                                                                                                                                                                                                                                                  |
| 10.6.3^^ |   | Third Amendment to Credit Agreement                                                                                                                                                                                                                   |
|     |   |                                                                                                                                                                                                                                                  |
| 10.6.4^^ |   | Fourth Amendment to Credit Agreement                                                                                                                                                                                                                  |
|     |   |                                                                                                                                                                                                                                                  |
| 10.7     |   | Security Agreement, by and between Greenway Medical Technologies, Inc. and Bank of America, N.A., dated as of March 22, 2011 (incorporated by reference to Exhibit 10.7 to the Company’s Form S-1 (File No. 333-175619) filed on July 15, 2011) |

 

| 10.8+   |   | Software License and Services Agreement, by and between Greenway Medical Technologies, Inc. and Walgreen Co., dated as of February 28, 2011 (incorporated by reference to Exhibit 10.8 to the Company’s Form S-1/A (File No. 333-175619) filed on December 5, 2011) |
|---------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|    |   |                                                                                                                                                                                                                                                                      |
| 10.9*   |   | Form of 2011 Incentive Bonus Plan (incorporated by reference to Exhibit 10.9 to the Company’s Form S-1/A (File No. 333-175619) filed on January 18, 2012)                                                                                                           |
|    |   |                                                                                                                                                                                                                                                                      |
| 10.10*+ |   | Form of 2012 Incentive Bonus Plan (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on March 5, 2012)                                                                                                                                      |
|    |   |                                                                                                                                                                                                                                                                      |
| 10.11*+ |   | Form of 2013 Incentive Bonus Plan (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on September 29, 2012)                                                                                                                                 |
|    |   |                                                                                                                                                                                                                                                                      |
| 10.12*  |   | Form of Greenway Medical Technologies, Inc. 2011 Stock Plan Stock Option Award Agreement (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed on March 5, 2012)                                                                               |
|    |   |                                                                                                                                                                                                                                                                      |
| 14.1    |   | Greenway Medical Technologies, Inc. Code of Business Conduct and Ethics (incorporated by reference to Exhibit 14 to the Company’s Form S-1/A (File No. 333-175619) filed on January 18, 2012)                                                                       |
|    |   |                                                                                                                                                                                                                                                                      |
| 21^^    |   | List of subsidiaries                                                                                                                                                                                                                                                      |
|    |   |                                                                                                                                                                                                                                                                      |
| 23.1^^  |   | Consent of Grant Thornton LLP                                                                                                                                                                                                                                             |
|    |   |                                                                                                                                                                                                                                                                      |
| 31.1^   |   | Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                                    |
|    |   |                                                                                                                                                                                                                                                                      |
| 31.2^   |   | Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                                    |
|    |   |                                                                                                                                                                                                                                                                      |
| 32.1^   |   | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002                                                                                             |
|    |   |                                                                                                                                                                                                                                                                      |
| 101^^   |   | Interactive Data File**                                                                                                                                                                                                                                                   |

----

| ^      | Filed herewith                                                                                                                                                                      |   |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|   |                                                                                                                                                                                |   |
| ^^     | These exhibits were previously filed with our Annual Report on Form 10-K for the year ended June 30, 2013, filed with the Securities and Exchange Commission on September 13, 2013. |
|   |                                                                                                                                                                                |
| *      | Denotes management contract or compensatory arrangement.                                                                                                                            |
|   |                                                                                                                                                                                |
| +      | Certain portions have been omitted pursuant to a confidential treatment request. Omitted information will be filed separately with the SEC.                                         |
|   |                                                                                                                                                                                |

 

|   |                                  |                    |   |
|--------|---------------------------------------|-------------------------|--------|
|   | GREENWAY MEDICAL TECHNOLOGIES, INC.   |
|   |                                  |                    |
|   | By:                              | /s/ Wyche T. Green, III |   |
|   |                                  |                    |
|   | Wyche T. Green, III                   |
|   | President and Chief Executive Officer |

|                     |      |                                         |             |   |   |   |   |   |   |
|--------------------------|-----------|----------------------------------------------|------------------|--------|--------|--------|--------|--------|--------|
|                     | Signature |                                         |             |   | Title  |   |   | Date   |   |
|                     |      |                                         |             |
| /s/ Wyche T. Green, III  |      | President, Chief Executive Officer, Director | October 28, 2013 |
| Wyche T. Green, III      |      | (Principal Executive Officer)                |             |
|                     |      |                                         |             |
| /s/ W. Thomas Green, Jr. |      | Chairman of the Board of Directors           | October 28, 2013 |
| W. Thomas Green, Jr.     |      |                                         |             |
|                     |      |                                         |             |
| /s/ James A. Cochran     |      | Chief Financial Officer                      | October 28, 2013 |
| James A. Cochran         |      | (Principal Financial and Accounting Officer) |             |
|                     |      |                                         |             |
| /s/ Noah Walley          |      |                                         |             |
| Noah Walley              |      | Director                                     | October 28, 2013 |
|                     |      |                                         |             |
| /s/ Thomas T. Richards   |      | Director                                     | October 28, 2013 |
| Thomas T. Richards       |      |                                         |             |
|                     |      |                                         |             |
| /s/ Walter Turek         |      | Director                                     | October 28, 2013 |
| Walter Turek             |      |                                         |             |
|                     |      |                                         |             |
| /s/ Neal Morrison        |      | Director                                     | October 28, 2013 |
| Neal Morrison            |      |                                         |             |
|                     |      |                                         |             |
| /s/ Robert Hensley       |      | Director                                     | October 28, 2013 |
| Robert Hensley           |      |                                         |             |